Dyslipidemia Clinical Trials

12 recruiting

Frequently Asked Questions

Common questions about Dyslipidemia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 31 trials

Recruiting
Not Applicable

Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)

Dyslipidemia Associated With Type II Diabetes Mellitus
Sin Gon Kim2,186 enrolled2 locationsNCT07359105
Recruiting
Not Applicable

PILI 'Āina Household

HypertensionType 2 DiabetesOverweight and Obesity+1 more
University of Hawaii210 enrolled2 locationsNCT06526273
Recruiting
Not Applicable

'Ai Pono Cooking Demonstrations

HypertensionType 2 DiabetesOverweight and Obesity+1 more
University of Hawaii1,780 enrolled2 locationsNCT06526650
Recruiting
Not Applicable

Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study

ObesityHypertensionOverweight+4 more
Universidad Católica San Antonio de Murcia220 enrolled1 locationNCT07447362
Recruiting
Not Applicable

A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

Diabetes MellitusObesityHypertension+2 more
University of Connecticut72 enrolled3 locationsNCT07238556
Recruiting
Phase 3

Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia

Type 2 DiabetesDyslipidemia
CMG Pharmaceutical Co. Ltd240 enrolled24 locationsNCT06772168
Recruiting

Taining Golden Lake Comprehensive Chronic Disease Management Initiative

SarcopeniaDiabetes MellitusHypertension+4 more
First Affiliated Hospital of Fujian Medical University20,000 enrolled1 locationNCT07308314
Recruiting
Phase 2

Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)

Cardiovascular DiseasesHIV InfectionsAtherosclerosis+1 more
Priscilla Hsue, MD121 enrolled3 locationsNCT05488431
Recruiting
Phase 3

Efficacy and Safety of Berlim 25/20 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia.

Dyslipidemia Associated With Type II Diabetes Mellitus
EMS228 enrolled1 locationNCT04602754
Recruiting

Military Health and Nutrition Examination Study

Cardiovascular DiseasesHypertensionType 2 Diabetes+1 more
Pennington Biomedical Research Center650 enrolled3 locationsNCT06380322
Recruiting

Gut Microbiota in Metabolic Surgery

Cardiovascular DiseasesHypertensionType 2 Diabetes+3 more
Vanderbilt University Medical Center300 enrolled1 locationNCT05000996
Recruiting
Not Applicable

Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults

HypertensionObesity, OverweightDyslipidemia+2 more
Kennesaw State University200 enrolled1 locationNCT07221279
Recruiting

Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography

Diabetes MellitusHypertensionDyslipidemias
Beijing Tongren Hospital300 enrolled1 locationNCT05644548
Recruiting
Phase 3

Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients With Hypertension and Dyslipidemia

HypertensionDyslipidemia
JW Pharmaceutical162 enrolled1 locationNCT06643130
Recruiting

Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens

Obesity and OverweightMetabolic SyndromeHypertension+7 more
Shanghai Changzheng Hospital4,094 enrolled1 locationNCT07043166
Recruiting
Not Applicable

Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial

Metabolic SyndromeHypertensionDiabetes+5 more
Indiana University20 enrolled1 locationNCT07119658
Recruiting
Not Applicable

Culturally Adapted Dietary Clinical Trial in PR

ObesityHypertensionDiabetes Mellitus, Type 2+4 more
Harvard School of Public Health (HSPH)250 enrolled1 locationNCT05962372
Recruiting

Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US

HypertensionType 2 DiabetesHIV-1-infection+1 more
Duke University150 enrolled2 locationsNCT05129345
Recruiting
Not Applicable

Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients

Diabetes MellitusHypertensionDyslipidemia+1 more
Saint Vincent's Hospital, Korea348 enrolled1 locationNCT07045623
Recruiting

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

ObesityCardiovascular DiseasesChronic Kidney Diseases+8 more
Swiss Tropical & Public Health Institute1,200 enrolled1 locationNCT05881447